1
|
Salami M, Alinaghipour A, Daneshvar R, Hamidi GA, Agahi A, Soheili M, Akbari H, Esmaeili Taba SM. Adapted MMSE and TYM cognitive tests: how much powerful in screening for Alzheimer's disease in Iranian people. Aging Ment Health 2020; 24:1010-1017. [PMID: 30884962 DOI: 10.1080/13607863.2019.1584786] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
Alzheimer's disease (AD) is a major global health priority and providing an efficient way for early diagnosis of people developing dementia is important. The Mini-Mental State Examination (MMSE, total score = 30) and Test Your Memory (TYM, total score = 50) are widely used as screening tests for cognitive function. In the present study 174 subjects including healthy people (CON group) and those having Alzheimer's disease (AD group) were introduced to MMSE and TYM cognitive tests adjusted to Iranian population. Sensitivities and specificities with optimal cut-off scores, area under curve (AUC), positive predictive value (PPV) and negative predictive value (NPV) were measured for both tests. The MMSE scores of the CON and AD groups were 23.77 ± 0.327 and 10.88 ± 0.762, respectively. The TYM scores were 44.32 ± 0.389 and 14.37 ± 1.368 in the CON and AD participants, respectively. Findings in the MMSE test were: AUC = 0.962, optimal cut-off score = 18.5, sensitivity = 0.90 and specificity = 0.96. Values in the TYM test were: AUC = 0.991, optimal cut-off score = 31, sensitivity = 0.90 and specificity = 1. We found no correlation between the cognitive performance and age in the CON group but a positive correlation in the AD patients. On the other hand, t-test analysis indicated that achievement of the test scores are significantly sex dependent, with more scores attained by the females. Taken together, in regard to correct classification rate (CCR); the TYM test seems to be more appropriate for cognitive screening in our study. However, considering an analogous AUC, both tests are comparable and have high sensitivity and specificity for discriminating between people with and without AD.
Collapse
Affiliation(s)
- M Salami
- Physiology Research Center, Kashan University of Medical Sciences, Kashan, Iran
| | - A Alinaghipour
- Department of Physiology School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
| | - R Daneshvar
- Department of Neurology School of Medicine, Kashan University of Medical Sciences, Kashan, Iran
| | - G A Hamidi
- Physiology Research Center, Kashan University of Medical Sciences, Kashan, Iran
| | - A Agahi
- Physiology Research Center, Kashan University of Medical Sciences, Kashan, Iran
| | - M Soheili
- Physiology Research Center, Kashan University of Medical Sciences, Kashan, Iran
| | - H Akbari
- Department of Statistics School of Health, Kashan University of Medical Sciences, Kashan, Iran
| | - S M Esmaeili Taba
- Taleghani Branch Department of Education, Farhangian University, Qom, Iran
| |
Collapse
|
2
|
McGavigan AK, O'Hara HC, Amin A, Kinsey-Jones J, Spreckley E, Alamshah A, Agahi A, Banks K, France R, Hyberg G, Wong C, Bewick GA, Gardiner JV, Lehmann A, Martin NM, Ghatei MA, Bloom SR, Murphy KG. L-cysteine suppresses ghrelin and reduces appetite in rodents and humans. Int J Obes (Lond) 2014; 39:447-55. [PMID: 25219528 PMCID: PMC4276721 DOI: 10.1038/ijo.2014.172] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/16/2014] [Revised: 08/28/2014] [Accepted: 09/08/2014] [Indexed: 12/13/2022]
Abstract
BACKGROUND High-protein diets promote weight loss and subsequent weight maintenance, but are difficult to adhere to. The mechanisms by which protein exerts these effects remain unclear. However, the amino acids produced by protein digestion may have a role in driving protein-induced satiety. METHODS We tested the effects of a range of amino acids on food intake in rodents and identified l-cysteine as the most anorexigenic. Using rodents we further studied the effect of l-cysteine on food intake, behaviour and energy expenditure. We proceeded to investigate its effect on neuronal activation in the hypothalamus and brainstem before investigating its effect on gastric emptying and gut hormone release. The effect of l-cysteine on appetite scores and gut hormone release was then investigated in humans. RESULTS l-Cysteine dose-dependently decreased food intake in both rats and mice following oral gavage and intraperitoneal administration. This effect did not appear to be secondary to behavioural or aversive side effects. l-Cysteine increased neuronal activation in the area postrema and delayed gastric emptying. It suppressed plasma acyl ghrelin levels and did not reduce food intake in transgenic ghrelin-overexpressing mice. Repeated l-cysteine administration decreased food intake in rats and obese mice. l-Cysteine reduced hunger and plasma acyl ghrelin levels in humans. CONCLUSIONS Further work is required to determine the chronic effect of l-cysteine in rodents and humans on appetite and body weight, and whether l-cysteine contributes towards protein-induced satiety.
Collapse
Affiliation(s)
- A K McGavigan
- Department of Investigative Medicine, Imperial College London, London, UK
| | - H C O'Hara
- Department of Investigative Medicine, Imperial College London, London, UK
| | - A Amin
- Department of Investigative Medicine, Imperial College London, London, UK
| | - J Kinsey-Jones
- Department of Investigative Medicine, Imperial College London, London, UK
| | - E Spreckley
- Department of Investigative Medicine, Imperial College London, London, UK
| | - A Alamshah
- Department of Investigative Medicine, Imperial College London, London, UK
| | - A Agahi
- Department of Investigative Medicine, Imperial College London, London, UK
| | - K Banks
- Department of Investigative Medicine, Imperial College London, London, UK
| | - R France
- Department of Investigative Medicine, Imperial College London, London, UK
| | - G Hyberg
- AstraZeneca R&D, Mölndal, Sweden
| | - C Wong
- Department of Investigative Medicine, Imperial College London, London, UK
| | - G A Bewick
- 1] Department of Investigative Medicine, Imperial College London, London, UK [2] Division of Diabetes & Nutritional Sciences, King's College London, London, UK
| | - J V Gardiner
- Department of Investigative Medicine, Imperial College London, London, UK
| | - A Lehmann
- 1] AstraZeneca R&D, Mölndal, Sweden [2] NextRx, Gothenburg, Sweden
| | - N M Martin
- Department of Investigative Medicine, Imperial College London, London, UK
| | - M A Ghatei
- Department of Investigative Medicine, Imperial College London, London, UK
| | - S R Bloom
- Department of Investigative Medicine, Imperial College London, London, UK
| | - K G Murphy
- Department of Investigative Medicine, Imperial College London, London, UK
| |
Collapse
|
3
|
Abstract
Obesity is a leading cause of morbidity and mortality worldwide. There is still a wide disparity between the necessity and availability of safe and effective antiobesity pharmacotherapies. Current drugs are associated with adverse effects and are limited in their efficacy. There is thus an urgent need for new antiobesity agents. Animal models are critical to the study of the biological mechanisms underpinning energy homeostasis and obesity and provide useful tools for the development of novel antiobesity agents. Our understanding of the complex neuronal and hormonal systems that regulate appetite and body weight has largely been based on studies in animals. This review describes the physiological basis of appetite, rodent models used in the development of antiobesity drugs, and potential future targets for novel antiobesity agents.
Collapse
Affiliation(s)
- A. Agahi
- Section of Investigative Medicine, Imperial College London, Hammersmith Hospital Campus, London, UK
| | - K. G. Murphy
- Section of Investigative Medicine, Imperial College London, Hammersmith Hospital Campus, London, UK
| |
Collapse
|